![](/img/cover-not-exists.png)
Phase I Study of B43-PAP Immunotoxin in Combination with Standard 4-Drug Induction for Patients with CD 19+ Acute Lymphoblastic Leukemia (ALL) in Relapse, A Children's Cancer Group Study
Seibel, N L, Krailo, M, O'Neill, K, Franklin, J, Uckun, F, Reaman, G HVolume:
45
Journal:
Pediatric Research
DOI:
10.1203/00006450-199905010-00225
Date:
May, 1999
File:
PDF, 70 KB
1999